| Oxidative stress and inflammation interdependence in multiple sclerosis R Padureanu, CV Albu, RR Mititelu, MV Bacanoiu, AO Docea, D Calina, ... Journal of clinical medicine 8 (11), 1815, 2019 | 98 | 2019 |
| Inflammatory and oxidative stress markers—mirror tools in rheumatoid arthritis RR Mititelu, R Pădureanu, M Băcănoiu, V Pădureanu, AO Docea, ... Biomedicines 8 (5), 125, 2020 | 79 | 2020 |
| Neutrophil to lymphocyte ratio (NLR)—a useful tool for the prognosis of sepsis in the ICU AN Drăgoescu, V Pădureanu, AD Stănculescu, LC Chiuțu, P Tomescu, ... Biomedicines 10 (1), 75, 2021 | 62 | 2021 |
| Role of antioxidants and oxidative stress in the evolution of acute pancreatitis V Pădureanu, DN Florescu, R Pădureanu, AE Ghenea, DI Gheonea, ... Experimental and Therapeutic Medicine 23 (3), 1-5, 2022 | 33 | 2022 |
| Presepsin as a potential prognostic marker for sepsis according to actual practice guidelines AN Drăgoescu, V Pădureanu, AD Stănculescu, LC Chiuțu, DN Florescu, ... Journal of Personalized Medicine 11 (1), 2, 2020 | 29 | 2020 |
| Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections D Dop, IR Marcu, R Padureanu, CE Niculescu, V Padureanu Experimental and Therapeutic Medicine 21 (1), 1-1, 2021 | 27 | 2021 |
| Perceptions of COVID-19 vaccination among healthcare professionals in Romania V Padureanu, M Bogdan, MS Subtirelu, R Padureanu, A Turcu-Stiolica, ... stress 22, 25, 2020 | 24 | 2020 |
| Insulin resistance quantified by the value of HOMA‑IR and cardiovascular risk in patients with type 2 diabetes IM Vladu, M Forțofoiu, D Clenciu, MC Forțofoiu, R Pădureanu, L Radu, ... Experimental and therapeutic medicine 23 (1), 1-6, 2022 | 19 | 2022 |
| Influence of multidisciplinary therapeutic approach on fibromyalgia patients S Pătru, R Pădureanu, F Dumitrescu, V Pădureanu, D Rădulescu, ... Experimental and therapeutic medicine 21 (5), 1-6, 2021 | 14 | 2021 |
| Therapy side effects in systemic lupus erythematosus R POPA, LA LAUTARU, R LUCRETIU, DC RUIU, D CARAGEA, ... Current health sciences journal 44 (3), 316, 2018 | 13 | 2018 |
| Homocysteine as a predictor tool in multiple sclerosis RR Mititelu, CV Albu, MV Bacanoiu, V Padureanu, R Padureanu, G Olaru, ... Discoveries 9 (3), 2021 | 7 | 2021 |
| Rheumatic Immune-Related Adverse Events—A Consequence of Immune Checkpoint Inhibitor Therapy A Bobircă, F Bobircă, I Ancuta, A Florescu, V Pădureanu, DN Florescu, ... Biology 10 (6), 561, 2021 | 6 | 2021 |
| The role of clinical and ultrasound enthesitis scores in ankylosing spondylitis A Florescu, V Pădureanu, DN Florescu, A Bobircă, LM Florescu, ... Life 11 (3), 218, 2021 | 6 | 2021 |
| Personal autonomy as quality of life predictor for multiple sclerosis patients R Padureanu, CV Albu, I Pirici, RR Mititelu, MS Subtirelu, ... Journal of clinical medicine 9 (5), 1349, 2020 | 6 | 2020 |
| Oxidative stress and vitamin D as predictors in multiple sclerosis R PĂdureanu, CV Albu, V PĂdureanu, AM BugĂ Current Health Sciences Journal 46 (4), 371, 2020 | 5 | 2020 |
| Non-steroidal anti-inflammatory drug etoricoxib facilitates the application of individualized exercise programs in patients with ankylosing spondylitis IR Marcu, D Dop, V Padureanu, SA Niculescu, R Padureanu, ... Medicina 56 (6), 270, 2020 | 5 | 2020 |
| Determination of VEGFR-2 (KDR)-604A> G polymorphism in recurrent pregnancy loss L Boldeanu, CA Siloşi, V Pădureanu, AL Dijmărescu, MM Manolea, ... Rom J Morphol Embryol 59 (4), 1053-1059, 2018 | 5 | 2018 |
| Non‑alcoholic fatty liver disease and hematologic manifestations V Pădureanu, D Dop, AN Drăgoescu, R Pădureanu, AE Mușetescu, ... Experimental and Therapeutic Medicine 22 (6), 1-4, 2021 | 4 | 2021 |
| The Role of the Body Mass Index in the Acute Pancreatitis Evolution V Padureanu, DN Florescu, R Padureanu, D Radulescu, MM Pomacu, ... Curr Health Sci J 47 (1), 49-53, 2021 | 4 | 2021 |
| Prothrombotic status in COVID‑19 with diabetes mellitus RM Mitroi, V Padureanu, A Mitrea, DC Protasiewicz Timofticiuc, MM Rosu, ... Biomedical reports 19 (4), 1-9, 2023 | 3 | 2023 |
